Recent studies also revealed that miR-31-5p may be a useful prognostic biomarker for anti-EGFR therapy in CRC because high miR-31-5p expression was associated with shorter progression-free survival [27]. The gene discussed is EGFR; the disease is colorectal carcinoma.